Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide

INTRODUCTION: Short‐course preventive therapy with 1‐month course of daily administration of isoniazid (300‐mg) plus rifapentine (600‐mg) (1HP) and 3‐month course of weekly administration of isoniazid (900‐mg) plus rifapentine (900‐mg) (3HP) has higher completion rates than 9‐month course of daily i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liou, Bo‐Huang, Cheng, Chih‐Ning, Lin, Ya‐Ting, Lin, Yu‐Jou, Chuang, Yu‐Chung, Lin, Kuan‐Yin, Liu, Wen‐Chun, Lin, Shu‐Wen, Kuo, Ching‐Hua, Sun, Hsin‐Yun, Hung, Chien‐Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614225/
https://www.ncbi.nlm.nih.gov/pubmed/34822220
http://dx.doi.org/10.1002/jia2.25844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614225/
https://www.ncbi.nlm.nih.gov/pubmed/34822220
http://dx.doi.org/10.1002/jia2.25844

Ejemplares similares